95 related articles for article (PubMed ID: 30138705)
1. Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity.
Ishiguro Y; Kobayashi M; Ideno M; Narumi K; Furugen A; Iseki K
Int J Pharm; 2018 Nov; 551(1-2):97-102. PubMed ID: 30138705
[TBL] [Abstract][Full Text] [Related]
2. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
[TBL] [Abstract][Full Text] [Related]
4. 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
Wang TA; Zhang XD; Guo XY; Xian SL; Lu YF
Oncol Rep; 2016 Mar; 35(3):1287-96. PubMed ID: 26708213
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma.
Schaefer NG; Geschwind JF; Engles J; Buchanan JW; Wahl RL
Transl Res; 2012 Jan; 159(1):51-7. PubMed ID: 22153810
[TBL] [Abstract][Full Text] [Related]
7. Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer.
Chapiro J; Sur S; Savic LJ; Ganapathy-Kanniappan S; Reyes J; Duran R; Thiruganasambandam SC; Moats CR; Lin M; Luo W; Tran PT; Herman JM; Semenza GL; Ewald AJ; Vogelstein B; Geschwind JF
Clin Cancer Res; 2014 Dec; 20(24):6406-17. PubMed ID: 25326230
[TBL] [Abstract][Full Text] [Related]
8. [Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro].
Li QX; Zhang P; Liu F; Wang XZ; Li L; Wang ZK; Jiang CC; Zheng HL; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):588-593. PubMed ID: 28539279
[TBL] [Abstract][Full Text] [Related]
9. 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.
Liu Z; Sun Y; Hong H; Zhao S; Zou X; Ma R; Jiang C; Wang Z; Li H; Liu H
Am J Cancer Res; 2015; 5(9):2673-85. PubMed ID: 26609475
[TBL] [Abstract][Full Text] [Related]
10. The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells.
Hosein AN; Lim YC; Day B; Stringer B; Rose S; Head R; Cosgrove L; Sminia P; Fay M; Martin JH
J Neurooncol; 2015 Apr; 122(2):263-71. PubMed ID: 25648357
[TBL] [Abstract][Full Text] [Related]
11. Antiglycolytic therapy combined with an image-guided minimally invasive delivery strategy for the treatment of breast cancer.
Buijs M; Wijlemans JW; Kwak BK; Ota S; Geschwind JF
J Vasc Interv Radiol; 2013 May; 24(5):737-43. PubMed ID: 23489770
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer.
Ota S; Geschwind JF; Buijs M; Wijlemans JW; Kwak BK; Ganapathy-Kanniappan S
Target Oncol; 2013 Jun; 8(2):145-51. PubMed ID: 23529644
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.
Orue A; Chavez V; Strasberg-Rieber M; Rieber M
BMC Cancer; 2016 Nov; 16(1):902. PubMed ID: 27863474
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Vali M; Liapi E; Kowalski J; Hong K; Khwaja A; Torbenson MS; Georgiades C; Geschwind JF
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):95-101. PubMed ID: 17296709
[TBL] [Abstract][Full Text] [Related]
16. 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway.
Liu Z; Zhang YY; Zhang QW; Zhao SR; Wu CZ; Cheng X; Jiang CC; Jiang ZW; Liu H
Anticancer Drugs; 2014 Apr; 25(4):447-55. PubMed ID: 24492287
[TBL] [Abstract][Full Text] [Related]
17. Brain Distribution and Efficacy of the Brain Penetrant PI3K Inhibitor GDC-0084 in Orthotopic Mouse Models of Human Glioblastoma.
Salphati L; Alicke B; Heffron TP; Shahidi-Latham S; Nishimura M; Cao T; Carano RA; Cheong J; Greve J; Koeppen H; Lau S; Lee LB; Nannini-Pepe M; Pang J; Plise EG; Quiason C; Rangell L; Zhang X; Gould SE; Phillips HS; Olivero AG
Drug Metab Dispos; 2016 Dec; 44(12):1881-1889. PubMed ID: 27638506
[TBL] [Abstract][Full Text] [Related]
18. ω3-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: In vitro and in vivo.
Kim S; Jing K; Shin S; Jeong S; Han SH; Oh H; Yoo YS; Han J; Jeon YJ; Heo JY; Kweon GR; Park SK; Park JI; Wu T; Lim K
Oncol Rep; 2018 Jan; 39(1):239-246. PubMed ID: 29192322
[TBL] [Abstract][Full Text] [Related]
19. 5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells.
Quezada C; Garrido W; Oyarzún C; Fernández K; Segura R; Melo R; Casanello P; Sobrevia L; San Martín R
J Cell Physiol; 2013 Mar; 228(3):602-8. PubMed ID: 22833450
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
